期刊文献+

3种稀释蝰蛇毒磷脂时间试验检测狼疮抗凝物的性能评价

Performance evaluation of three diluted Russell viper venom time tests for the detection of lupus anticoagulant
下载PDF
导出
摘要 目的对3种稀释蝰蛇毒磷脂时间试验(dRVVT)的狼疮抗凝物(LA)检测方法进行性能评价,比较不同系统间检测结果的一致性,并初步探讨不同检验流程对检测结果的影响。方法按照美国临床和实验室标准协会(CLSI)文件及临床血液学检测常规项目分析质量文件(WS/T 406—2012),对3种LA检测方法的精密度、携带污染率进行评价,验证3种方法检测LA的参考区间(RI)/cut-off值,并分析检验结果一致性和不同检验流程对检测结果的影响。结果3种dRVVT检测方法重复性以CV表示为0.44%~1.69%;期间精密度以CV表示,为1.43%~2.43%。3种检测方法携带污染率绝对值<3.00%。系统1和2的RI验证通过,系统3验证未通过。3种不同系统筛选试验、确认试验及比值间结果差异有统计学意义(P=0.000)。3种不同系统阴阳性判断结果间差异有统计学意义(χ^2=11.333,P=0.000)。系统3以说明书推荐流程分析结果,与筛选/确认比值(R)或标准化比值(NR)结果表示方式相比,53例阴性结果中2例为假阴性。结论3种dRVVT检测系统性能良好,适于临床常规使用。但各实验室应验证或建立适合本实验室的RI/cut-off值,确定合理的检测流程,关注检测分析前中后影响因素,合理解释检测结果。 Objective To evaluate the performance of three diluted Russell viper venom time(dRVVT)tests for the detection of lupus anticoagulant(LA),compare the consistency of detection results from different systems,and preliminarily investigate the influence of different test processes on the detection results.Methods According to the Clinical and Laboratory Standards Institute(CLSI)standardizations and analytical quality specifications for routine tests in clinical hematology(WS/T 406—2012),the precision and carry-over contamination rates of three dRVVT tests were evaluated,the reference interval(RI)/cut-off values of three dRVVT tests for the detection of LA were validated,and the consistency of detection results and the influence of different procedures on the detection results were analyzed.Results The within-run and between-run coefficients of variation(CV)of three dRVVT tests were 0.44%to 1.69%and 1.43%to 2.43%,respectively.The absolute values of carryover contamination rates of three tests were less than 3.00%.The verification of RI/cut-off values of system 1 and 2 were passed,while that of system 3 was failed.There were statistical differences in the results of screening tests,confirmatory tests and normalized ratios of three systems(P=0.000).There were significant differences in the evaluation of positive and negative results for three systems(χ^2=11.333,P=0.000).When the results of system 3 were analyzed with the recommended process of the manual and the results were compared with those expressed by LA-R or LA-NR,2 out of 53 negative results were false negative.Conclusion Three dRVVT detection systems have good performance and are suitable for clinical routine use.However,each laboratory should verify or establish a suitable RI/cut-off value for the laboratory,determine a suitable testing process,pay attention to the influencing factors of the whole process of analysis,and reasonably interpret the detection results.
作者 寿玮龄 陈倩 范连凯 张建平 吴卫 SHOU Weiling;CHEN Qian;FAN Liankai;ZHANG Jianping;WU Wei(Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China)
出处 《临床检验杂志》 CAS 2020年第10期734-737,共4页 Chinese Journal of Clinical Laboratory Science
关键词 狼疮抗凝物 稀释蝰蛇毒磷脂时间试验 性能验证 参考区间/cut-off值 lupus anticoagulant diluted Russell viper venom time test performance validation reference interval/cut-off value
  • 相关文献

参考文献2

二级参考文献25

  • 1Shoenfeld Y, Meroni PL, Gershwin ME. Autoantibodies[ M]. Third Edition. Elsevier: 2014.
  • 2Fangtham M, Petri M. 2013 update: Hopkins lupus cohort[J]. Curr Rheumatol Rep, 2013, 15(9) :360.
  • 3Lockshin MD, Kim M, Laskin CA, et al. Prediction of adverse preg- nancy outcome by the presence of lupus anticoagulant, but not anti- cardiolipin antibody, in patients with antiphospholipid antibodies [ J ]. Arthritis Rheum, 2012, 64(7) : 2311-2315.
  • 4Bertolaccini ML, Amengual O, Andreoli L, et al. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on an- tiphospholipid syndrome laboratory diagnostics and trends [ J ]. Auto- immun Rev, 2014, 13(9) : 917-930.
  • 5Gebhart J, Posch F, Koder S, et al. Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS) [ J ]. Blood, 2015, 125 (22) : 3477- 3483.
  • 6AI Jameil N, Tyagi P, A1 Shenefy A. Incidence of anticardiolipin an- tibodies and lupus anticoagulant factor among women experiencing un- explained recurrent abortion and intrauterine fetal death [ J ]. Int J Clin Exp Pathol, 2015, 8(3) : 3204-3209.
  • 7Poz A, Pradella P, Azzarini G, et al. Lupus anticoagulant: a multi- center study for a standardized and harmonized reporting [ J ]. Blood Coagul Fibrinolysis, 2016, 27 (2) : 176-184.
  • 8Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lu- pus anticoagulant detection[ J]. J Thromb Haemost, 2009, 7 (10) : 1737-1740.
  • 9Keeling D, Mackie I, Moore GW, et al. Guidelines on the investiga- tion and management of antiphospholipid syndrome [ J ]. Br J Haema- tol, 2012, 157(1 ) : 47-58.
  • 10CLSI. Laboratory Testing for the Lupus Anticoagulant; Approved Guideline CESI. document H60-A [ S ]. Wayne, PA : Clinical and Laboratory Standards Institute, 2014.

共引文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部